FOI 4998 – Medical Devices and Human Tissue Products (MDHTP) Rules and billing codes

This request relates to drafting and enactment of the PHI 66/23 Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No 2) 2023 (MDHTP Rules) which include any reference to, or which otherwise relate to, the condition concerning billing codes for surgical guides and biomodels.

Downloads

FOI 4998 – Medical Devices and Human Tissue Products (MDHTP) Rules and billing codes [pack 1]

FOI 4998 – Medical Devices and Human Tissue Products (MDHTP) Rules and billing codes [pack 2]

FOI 4998 – Medical Devices and Human Tissue Products (MDHTP) Rules and billing codes [pack 3]

FOI 4998 – Medical Devices and Human Tissue Products (MDHTP) Rules and billing codes [pack 4]

FOI 4998 – Medical Devices and Human Tissue Products (MDHTP) Rules and billing codes [pack 5]

FOI 4998 – Medical Devices and Human Tissue Products (MDHTP) Rules and billing codes [pack 6]

FOI 4998 – Medical Devices and Human Tissue Products (MDHTP) Rules and billing codes [pack 7]

FOI 4998 – Medical Devices and Human Tissue Products (MDHTP) Rules and billing codes [pack 8]

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

FOI number:
4998-2024
FOI release date:
Publication type:
Report
Audience:
General public
Description:

The FOI request to PHI 66/23 Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No 2) 2023 and includes:

Copies of notices, emails, recordings, phone records and file notes of calls, digital images, notes, draft documents and working documents, which:

  1. relate to or are otherwise connected with the drafting and enactment of the PHI 66/23 Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No 2) 2023 (MDHTP Rules); and/or
  2. which include any reference to, or which otherwise relate to, the condition concerning billing codes for surgical guides and biomodels, including but not limited to:
    1. documents relating to the Prescribed List post-listing review; and
    2. documents relating to the discussion conducted in September 2023 by the Medical Devices and Human Tissue Advisory Committee.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.